Chemoinformaics analysis of ASIATICENTOIC-ACID
| Molecular Weight | 133.103 | nRot | 3 |
| Heavy Atom Molecular Weight | 126.047 | nRig | 2 |
| Exact Molecular Weight | 133.038 | nRing | 0 |
| Solubility: LogS | -1.137 | nHRing | 0 |
| Solubility: LogP | -3.721 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 16 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 7 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 15.6556 |
| nHD | 3 | BPOL | 8.18845 |
| QED | 0.452 |
| Synth | 2.412 |
| Natural Product Likeliness | 1.08 |
| NR-PPAR-gamma | 0.051 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.056 |
| HIA | 0.012 |
| CACO-2 | -6.173 |
| MDCK | 0.00759793 |
| BBB | 0.358 |
| PPB | 0.0995225 |
| VDSS | 0.289 |
| FU | 0.842221 |
| CYP1A2-inh | 0.004 |
| CYP1A2-sub | 0.023 |
| CYP2c19-inh | 0.039 |
| CYP2c19-sub | 0.042 |
| CYP2c9-inh | 0.013 |
| CYP2c9-sub | 0.511 |
| CYP2d6-inh | 0.037 |
| CYP2d6-sub | 0.134 |
| CYP3a4-inh | 0.016 |
| CYP3a4-sub | 0.006 |
| CL | 9.451 |
| T12 | 0.667 |
| hERG | 0.009 |
| Ames | 0.029 |
| ROA | 0.031 |
| SkinSen | 0.158 |
| Carcinogencity | 0.044 |
| EI | 0.205 |
| Respiratory | 0.086 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.947917 |